Kuivaniemi H, Prockop D J, Wu Y, Madhatheri S L, Kleinert C, Earley J J, Jokinen A, Stolle C, Majamaa K, Myllylä V V
Department of Biochemistry and Molecular Biology, Jefferson Institute of Molecular Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19017-5541.
Neurology. 1993 Dec;43(12):2652-8. doi: 10.1212/wnl.43.12.2652.
We performed detailed DNA sequencing analysis on type III collagen cDNA from 58 patients with either intracranial artery aneurysms or cervical artery dissections. The 58 patients were of seven different nationalities; among the patients were three pairs of relatives, so that 55 were unrelated, and of these, 29 had at least one blood relative with either an intracranial artery aneurysm or a cervical artery dissection. The age of the patients at the time of diagnosis ranged from 15 to 68 years (mean +/- SD = 40.3 +/- 11.0). The study group consisted of 25 males and 33 females. The analysis covered 3,232 nucleotides of significant (nonredundant) sequences per allele; therefore, we analyzed as many as 355,520 nucleotides. Mutations in the coding sequences for the triple-helical domain of type III collagen were excluded in 40 individuals with intracranial aneurysms and 18 individuals with cervical artery dissections. Direct sequencing of polymerase chain reaction products allowed mutations to be excluded with a high degree of confidence. Mutations that markedly decreased expression from one allele were also excluded in 42 of the 58 individuals, since the presence of both bases at one or more polymorphic sites in the 42 patients showed that two alleles were transcribed. The results indicated that mutations in the gene for type III procollagen (COL3A1) are not a common cause of either intracranial artery aneurysms or cervical artery dissections.
我们对58例患有颅内动脉瘤或颈动脉夹层的患者的III型胶原蛋白cDNA进行了详细的DNA测序分析。这58例患者来自七个不同的国家;患者中有三对亲属,因此55例无亲属关系,其中29例至少有一位亲属患有颅内动脉瘤或颈动脉夹层。诊断时患者的年龄在15至68岁之间(平均±标准差 = 40.3±11.0)。研究组包括25名男性和33名女性。分析涵盖了每个等位基因3232个核苷酸的重要(非冗余)序列;因此,我们分析了多达355520个核苷酸。在40例颅内动脉瘤患者和18例颈动脉夹层患者中排除了III型胶原蛋白三螺旋结构域编码序列中的突变。聚合酶链反应产物的直接测序能够高度可靠地排除突变。在58例患者中的42例中也排除了明显降低一个等位基因表达的突变,因为这42例患者在一个或多个多态性位点上两个碱基的存在表明两个等位基因都被转录。结果表明,III型前胶原蛋白(COL3A1)基因的突变不是颅内动脉瘤或颈动脉夹层的常见病因。